延迟 Pembrolizumab 相关结节病。
Mesh : Humans Antibodies, Monoclonal, Humanized / adverse effects therapeutic use Sarcoidosis / chemically induced drug therapy Antineoplastic Agents, Immunological / adverse effects Male Female Middle Aged Melanoma / drug therapy Aged
来 源: DOI:10.1097/MJT.0000000000001674